WAM
EBS icon

Wealthspire Advisors (Maryland)’s Emergent Biosolutions EBS Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,210
Closed -$61K – 884
2019
Q1 		$61K Buy
1,210
+98
+9% +$5.78K ﹤0.01% 827
2018
Q4 		$66K Buy
1,112
+1,020
+1,109% +$65.8K 0.01% 746
2018
Q3 		$6K Buy
92
+14
+18% +$817 ﹤0.01% 1723
2018
Q2 		$4K Hold
78
– – ﹤0.01% 1872
2018
Q1 		$4K Hold
78
– – ﹤0.01% 1896
2017
Q4 		$4K Buy
78
+75
+2,500% +$3.16K ﹤0.01% 1895
2017
Q3 		$0 Buy
+3
New +$109 ﹤0.01% 2297

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s EBS Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 1,210 shares — an estimated $61K sold.

Wealthspire Advisors (Maryland) first reported a position in EBS in Q3 2017 and held it in 7 quarters. The position peaked at $66K in Q4 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,210 Emergent Biosolutions shares in Q2 2019, an estimated $61K.
  • Wealthspire Advisors (Maryland) first reported a position in Emergent Biosolutions in Q3 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s Emergent Biosolutions position peaked at $66K in Q4 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.